China conditionally approves four self-developed COVID-19 vaccines: official
Xinhua |
Updated: 2021-02-26 20:09
Share
Share - WeChat
BEIJING - China has granted conditional market approval to four self-developed COVID-19 vaccines, Minister of Science and Technology Wang Zhigang said Friday.
China has adopted five technological approaches in developing COVID-19 vaccines. China now has 17 self-developed COVID-19 vaccines undergoing clinical trials, with seven undergoing phase-3 clinical trials, Wang told a press conference held in Beijing.
China has also included 11 drugs and treatment methods in its diagnosis and treatment plan for COVID-19, Wang added.
- Xinjiang rides clean energy wave to power transition
- Concerns over Taiwan's economic outlook rise as key indicators dim
- Jimu 1 balloon breaks ground in Qinghai-Tibet Plateau expedition
- Wuhan University penalize academic staff members
- Former Hebei official investigated for serious violations
- Wuhan University revokes student's demerit following court ruling
